GoldenGolden
Advanced Search
Pontifax Venture Capital

Pontifax Venture Capital

Israeli venture capital firm funding Israeli bio-pharmaceutical and life science companies.

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Funding

Pontifax Venture Capital funds companies at various stages of development, from early stage to growth capital. It specializes in funding companies that are based in Israel. The firm prefers to fund companies operating in the pharmaceutical and life science industry sectors. Since January 2016, the firm has managed to raise $585 million through three funding rounds. Its most recent funding round was held in November 2018, amassing $170 million.

Timeline

Associated investment funds

People

Name
Role
LinkedIn

Ohad Hammer

Partner

Ran Nussbaum

Managing Partner/Partner/Founder

Tomer Kariv

Chief Executive Officer/Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

89bio

ABAC Therapeutics

Dynacure

Horama

Keros Therapeutics

Step Pharma

News

Title
Author
Date
Publisher
Description
Alex Keown
April 13, 2021
BioSpace
This morning, multiple companies announced hundreds of millions of dollars were raised in Series B rounds that will be used to advance therapeutics and business development programs.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.